Proposed Information Collection Activity; Case Plan Requirement, Title IV-E of the Social Security Act, (OMB #0970-0428), 38141-38142 [2020-13684]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 123 / Thursday, June 25, 2020 / Notices
responsible for making sure that your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include any sensitive personal
information, such as your or anyone
else’s Social Security number; date of
birth; driver’s license number or other
state identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure that your
comment does not include any sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
which . . . . is privileged or
confidential’’—as provided by Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule § 4.10(a)(2), 16 CFR
4.10(a)(2)—including in particular
competitively sensitive information
such as costs, sales statistics,
inventories, formulas, patterns, devices,
manufacturing processes, or customer
names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule
§ 4.9(c). In particular, the written
request for confidential treatment that
accompanies the comment must include
the factual and legal basis for the
request, and must identify the specific
portions of the comment to be withheld
from the public record. See FTC Rule
4.9(c). Your comment will be kept
confidential only if the General Counsel
grants your request in accordance with
the law and the public interest. Once
your comment has been posted publicly
at www.regulations.gov, we cannot
redact or remove your comment unless
you submit a confidentiality request that
meets the requirements for such
treatment under FTC Rule § 4.9(c), and
the General Counsel grants that request.
The FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding, as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before August 24, 2020. For information
on the Commission’s privacy policy,
including routine uses permitted by the
Privacy Act, see https://www.ftc.gov/
site-information/privacy-policy.
Josephine Liu,
Assistant General Counsel for Legal Counsel.
[FR Doc. 2020–13706 Filed 6–24–20; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Case Plan Requirement, Title
IV–E of the Social Security Act, (OMB
#0970–0428)
Administration on Children,
Youth and Families, Administration for
Children and Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Administration on
Children, Youth and Families (ACYF),
Administration for Children and
Families (ACF), U.S. Department of
Health and Human Services (HHS), is
requesting a 3-year extension of the
information collection—Case Plan
Requirement, Title IV–E of the Social
Security Act, (OMB #0970–0428,
expiration 3/31/2021). ACF is reporting
a change to the information collection—
the burden estimates in the previouslyapproved request were based on the
number of children in foster care as the
respondent instead of the agency
completing the case plan. The burden
estimates, therefore, are adjusted
accordingly.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
ACF is soliciting public comment on the
specific aspects of the information
collection described above.
SUMMARY:
38141
Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by emailing infocollection@
acf.hhs.gov. Alternatively, copies can
also be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation (OPRE), 330 C Street
SW, Washington, DC 20201, Attn: ACF
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
Description: The case plan information
collection is authorized in sections
422(b)(8)(A)(ii) and 471(a)(16), and
defined in sections 475 and 475A of the
Social Security Act (the Act). Statutory
requirements in the Act mandate that
states, territories, and tribes with an
approved title IV–E plan develop a case
plan and case review system for each
child in the foster care system for whom
the state, territory, or tribe receives title
IV–E reimbursement of foster care
maintenance payments.
The case review system assures that
each child has a case plan designed to
achieve placement in a safe setting that
is the least restrictive, most family-like
setting available and in close proximity
to the child’s parental home, consistent
with the best interest and special needs
of the child. States, territories, and
tribes meeting these requirements also
partly comply with title IV–B, section
422(b), of the Act, which assures certain
protections for children in foster care.
The case plan is a written document
that provides a narrative description of
the child-specific program of care.
Federal regulations at 45 CFR 1356.21(g)
and sections 475 and 475A of the Act
delineate the specific information that
must be addressed in the case plan. ACF
does not specify a format for the case
plan nor does ACF require submission
of the document to the federal
government. Case plan information is
recorded in a format developed and
maintained by the state, territorial, or
tribal title IV–E agency.
Respondents: State, territorial, and
tribal title IV–E agencies.
jbell on DSKJLSW7X2PROD with NOTICES
ANNUAL BURDEN ESTIMATES
Instrument
Total number
of respondents
Total number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Annual burden
hours
Case Plan ..........................................................................
64
26,427
4.8
8,118,374
2,706,125
Estimated Total Annual Burden
Hours: 2,706,125.
VerDate Sep<11>2014
19:15 Jun 24, 2020
Jkt 250001
Comments: The Department
specifically requests comments on (a)
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
whether the proposed collection of
information is necessary for the proper
E:\FR\FM\25JNN1.SGM
25JNN1
38142
Federal Register / Vol. 85, No. 123 / Thursday, June 25, 2020 / Notices
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: 42 U.S.C. 622; 42 U.S.C. 671;
42 U.S.C. 675.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–13684 Filed 6–24–20; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–D–0589]
Hospital-Acquired Bacterial
Pneumonia and Ventilator-Associated
Bacterial Pneumonia: Developing
Drugs for Treatment; Guidance for
Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a final
guidance for industry entitled
‘‘Hospital-Acquired Bacterial
Pneumonia and Ventilator-Associated
Bacterial Pneumonia: Developing Drugs
for Treatment.’’ The purpose of this
final guidance is to help sponsors and
investigators in the clinical
development of antibacterial drugs for
the treatment of hospital-acquired
bacterial pneumonia and ventilatorassociated bacterial pneumonia (HABP/
VABP) based on comments that were
received and current recommendations.
This guidance finalizes the draft
guidance of the same title issued on
May 7, 2014.
SUMMARY:
The announcement of the
guidance is published in the Federal
Register on June 25, 2020.
jbell on DSKJLSW7X2PROD with NOTICES
DATES:
You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
ADDRESSES:
VerDate Sep<11>2014
19:15 Jun 24, 2020
Jkt 250001
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2010–D–0589 for ‘‘Hospital-Acquired
Bacterial Pneumonia and VentilatorAssociated Bacterial Pneumonia:
Developing Drugs for Treatment.’’
Received comments will be placed in
the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of this guidance to the Division
of Drug Information, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10001 New
Hampshire Ave., Hillandale Building,
4th Floor, Silver Spring, MD 20993–
0002. Send one self-addressed adhesive
label to assist that office in processing
your requests. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the guidance document.
FOR FURTHER INFORMATION CONTACT:
Sunita Shukla, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, Rm. 6334,
Silver Spring, MD 20993–0002, 301–
796–6406.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a final guidance for industry entitled
‘‘Hospital-Acquired Bacterial
E:\FR\FM\25JNN1.SGM
25JNN1
]]>Agencies
[Federal Register Volume 85, Number 123 (Thursday, June 25, 2020)]
[Notices]
[Pages 38141-38142]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13684]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity; Case Plan Requirement,
Title IV-E of the Social Security Act, (OMB #0970-0428)
AGENCY: Administration on Children, Youth and Families, Administration
for Children and Families, HHS.
ACTION: Request for public comment.
-----------------------------------------------------------------------
SUMMARY: The Administration on Children, Youth and Families (ACYF),
Administration for Children and Families (ACF), U.S. Department of
Health and Human Services (HHS), is requesting a 3-year extension of
the information collection--Case Plan Requirement, Title IV-E of the
Social Security Act, (OMB #0970-0428, expiration 3/31/2021). ACF is
reporting a change to the information collection--the burden estimates
in the previously-approved request were based on the number of children
in foster care as the respondent instead of the agency completing the
case plan. The burden estimates, therefore, are adjusted accordingly.
DATES: Comments due within 60 days of publication. In compliance with
the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995, ACF is soliciting public comment on the specific aspects
of the information collection described above.
ADDRESSES: Copies of the proposed collection of information can be
obtained and comments may be forwarded by emailing
[email protected]. Alternatively, copies can also be obtained
by writing to the Administration for Children and Families, Office of
Planning, Research, and Evaluation (OPRE), 330 C Street SW, Washington,
DC 20201, Attn: ACF Reports Clearance Officer. All requests, emailed or
written, should be identified by the title of the information
collection.
SUPPLEMENTARY INFORMATION: Description: The case plan information
collection is authorized in sections 422(b)(8)(A)(ii) and 471(a)(16),
and defined in sections 475 and 475A of the Social Security Act (the
Act). Statutory requirements in the Act mandate that states,
territories, and tribes with an approved title IV-E plan develop a case
plan and case review system for each child in the foster care system
for whom the state, territory, or tribe receives title IV-E
reimbursement of foster care maintenance payments.
The case review system assures that each child has a case plan
designed to achieve placement in a safe setting that is the least
restrictive, most family-like setting available and in close proximity
to the child's parental home, consistent with the best interest and
special needs of the child. States, territories, and tribes meeting
these requirements also partly comply with title IV-B, section 422(b),
of the Act, which assures certain protections for children in foster
care.
The case plan is a written document that provides a narrative
description of the child-specific program of care. Federal regulations
at 45 CFR 1356.21(g) and sections 475 and 475A of the Act delineate the
specific information that must be addressed in the case plan. ACF does
not specify a format for the case plan nor does ACF require submission
of the document to the federal government. Case plan information is
recorded in a format developed and maintained by the state,
territorial, or tribal title IV-E agency.
Respondents: State, territorial, and tribal title IV-E agencies.
Annual Burden Estimates
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total number of Average burden
Instrument Total number of responses per hours per Total burden Annual burden
respondents respondent response hours hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Case Plan......................................................... 64 26,427 4.8 8,118,374 2,706,125
--------------------------------------------------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 2,706,125.
Comments: The Department specifically requests comments on (a)
whether the proposed collection of information is necessary for the
proper
[[Page 38142]]
performance of the functions of the agency, including whether the
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Authority: 42 U.S.C. 622; 42 U.S.C. 671; 42 U.S.C. 675.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2020-13684 Filed 6-24-20; 8:45 am]
BILLING CODE 4184-01-P
